Immunocore Holdings plc
IMCR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $247,771 | $249,428 | $144,235 | $36,484 |
| % Growth | -0.7% | 72.9% | 295.3% | – |
| Cost of Goods Sold | $8,388 | $1,037 | $5,294 | $0 |
| Gross Profit | $239,382 | $248,391 | $138,941 | $36,484 |
| % Margin | 96.6% | 99.6% | 96.3% | 100% |
| R&D Expenses | $177,441 | $163,545 | $84,311 | $100,248 |
| G&A Expenses | $0 | $0 | $0 | $119,307 |
| SG&A Expenses | $0 | $144,495 | $0 | $110,823 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$8,484 |
| Other Operating Expenses | $118,222 | $0 | $97,404 | $0 |
| Operating Expenses | $295,662 | $308,040 | $181,715 | $211,071 |
| Operating Income | -$56,280 | -$59,649 | -$42,774 | -$174,587 |
| % Margin | -22.7% | -23.9% | -29.7% | -478.5% |
| Other Income/Exp. Net | $13,997 | -$1,241 | $8,955 | -$5,292 |
| Pre-Tax Income | -$42,283 | -$60,890 | -$33,819 | -$179,879 |
| Tax Expense | -$1,478 | -$5,603 | $9,645 | $150 |
| Net Income | -$40,805 | -$55,287 | -$43,465 | -$180,029 |
| % Margin | -16.5% | -22.2% | -30.1% | -493.4% |
| EPS | -1.02 | -1.13 | -0.95 | -3.13 |
| % Growth | 9.7% | -18.9% | 69.6% | – |
| EPS Diluted | -1.02 | -1.13 | -0.95 | -3 |
| Weighted Avg Shares Out | 49,991 | 48,889 | 45,715 | 42,489 |
| Weighted Avg Shares Out Dil | 49,991 | 48,889 | 45,715 | 43,863 |
| Supplemental Information | – | – | – | – |
| Interest Income | $25,618 | $17,986 | $3,756 | $65 |
| Interest Expense | $18,844 | $5,154 | $5,409 | $5,573 |
| Depreciation & Amortization | $3,358 | $4,090 | $4,413 | $7,591 |
| EBITDA | -$38,504 | -$51,646 | -$38,355 | -$166,715 |
| % Margin | -15.5% | -20.7% | -26.6% | -457% |